
Comprehensive overview of COVID-19 research by Dr Philip McMillan, focusing on autoimmunity as the primary pathology in the disease.
| Platform | Pricing | Freemium | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 685 | Founded | 5 years ago | Last Issue | 4 days ago |
| Active | |||||

I was hesitant to discuss Dolly Parton’s death.
There is an obvious danger whenever a public figure dies and only limited medical information has been released. Grief can quickly be overtaken by speculation. A few facts can be arranged int...
Red cell distribution width is measured routinely in almost every full blood count. I am beginning to wonder whether we have underestimated what changes in this simple number might tell us after COVID
One of the biggest challenges I face c...
When I sat down with Dr Shankara Chetty and Joachim Gerlach, I expected the conversation to centre on Anthony Fauci, the DEFUSE proposal and the renewed argument over whether SARS-CoV-2 emerged from a laboratory (timecodes below).
It did b...
Eighteen months ago I wrote an article called “Profit Over Patients: The Remdesivir Scandal and the Cost of Corporate Influence.” My concern then was straightforward. During the pandemic, an extraordinarily expensive antiviral became embedd...
On 27 May 2021, Janet Woodcock emailed Francis Collins and Anthony Fauci. The subject line was “Vaccine adverse events.” She was not simply a senior FDA official at the time. She was the Acting Commissioner.
She wrote that a number of peop...
Subscribers, engagement, traffic and sponsorship for Vejon COVID-19 Review.
| Subscribers | Engagement | 83 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #58 | |
| #35 |
The writers behind this newsletter.
Physician and researcher with an innovative approach to COVID-19 and dementia reversal, international keynote speaker and LinkedIn Live influencer.
You can find recent issues that have been published by Vejon COVID-19 Review on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Vejon COVID-19 Review, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Vejon COVID-19 Review as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Vejon COVID-19 Review using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Vejon COVID-19 Review. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.